These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35129895)

  • 21. [Treatment of a terbinafine-resistant trichophyton mentagrophytes type VIII].
    Gawaz A; Nenoff P; Uhrlaß S; Schaller M
    Hautarzt; 2021 Oct; 72(10):900-904. PubMed ID: 34241651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral therapy of common superficial fungal infections of the skin.
    Lesher JL
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 2):S31-4. PubMed ID: 10367914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of Difficult-to-Treat Tinea Corporis Caused by Trichophyton mentagrophytes Complex Isolates, Paris, France.
    Dellière S; Joannard B; Benderdouche M; Mingui A; Gits-Muselli M; Hamane S; Alanio A; Petit A; Gabison G; Bagot M; Bretagne S
    Emerg Infect Dis; 2022 Jan; 28(1):224-228. PubMed ID: 34932462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
    Lebwohl M; Elewski B; Eisen D; Savin RC
    Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal resistance in dermatophytes: Recent trends and therapeutic implications.
    Khurana A; Sardana K; Chowdhary A
    Fungal Genet Biol; 2019 Nov; 132():103255. PubMed ID: 31330295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-week therapy with oral terbinafine in cases of tinea cruris/corporis.
    Farag A; Taha M; Halim S
    Br J Dermatol; 1994 Nov; 131(5):684-6. PubMed ID: 7999601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superficial fungal infections.
    Kelly BP
    Pediatr Rev; 2012 Apr; 33(4):e22-37. PubMed ID: 22474120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral terbinafine: a new antifungal agent.
    Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1997 Apr; 31(4):445-56. PubMed ID: 9101008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Trends of Using Systemic Antifungal Drugs and their Comparative Efficacy in Tinea Corporis and Tinea Cruris in Outpatient Department of Dermatology in a Tertiary Level Hospital.
    Sultana T; Saha SK; Hossain M; Ajmeri S; Sarker M; Sultana M; Nandi AK; Das PK
    Mymensingh Med J; 2018 Jan; 27(1):52-56. PubMed ID: 29459592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of DermaGenius
    Singh A; Singh P; Dingemans G; Meis JF; Chowdhary A
    Mycoses; 2021 Jul; 64(7):721-726. PubMed ID: 33760310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ajoene in the topical short-term treatment of tinea cruris and tinea corporis in humans. Randomized comparative study with terbinafine.
    Ledezma E; López JC; Marin P; Romero H; Ferrara G; De Sousa L; Jorquera A; Apitz Castro R
    Arzneimittelforschung; 1999 Jun; 49(6):544-7. PubMed ID: 10417874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tinea corporis bullosa due to Trichophyton schoenleinii: case report.
    Mareş M; Năstasă V; Apetrei IC; Suditu GC
    Mycopathologia; 2012 Oct; 174(4):319-22. PubMed ID: 22576942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study.
    Voravutinon V
    J Med Assoc Thai; 1993 Jul; 76(7):388-93. PubMed ID: 8089640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes.
    Rich P; Houpt KR; LaMarca A; Loven KH; Marbury TC; Matheson R; Miller B; Smith S; Wolf J;
    Cutis; 2001 Jul; 68(1 Suppl):15-22. PubMed ID: 11499330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal Susceptibility of Japanese Isolates of Nannizia fulva (Formerly Microsporum fulvum).
    Kano R; Oshimo K; Fukutomi T; Kamata H
    Med Mycol J; 2019; 60(1):23-25. PubMed ID: 30814467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caution and warning: Arrival of terbinafine-resistant Trichophyton interdigitale of the Indian genotype, isolated from extensive dermatophytosis, in Japan.
    Kimura U; Hiruma M; Kano R; Matsumoto T; Noguchi H; Takamori K; Suga Y
    J Dermatol; 2020 May; 47(5):e192-e193. PubMed ID: 32157721
    [No Abstract]   [Full Text] [Related]  

  • 37. A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: Genomic insights and resistance profile.
    Singh A; Masih A; Monroy-Nieto J; Singh PK; Bowers J; Travis J; Khurana A; Engelthaler DM; Meis JF; Chowdhary A
    Fungal Genet Biol; 2019 Dec; 133():103266. PubMed ID: 31491507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and management of tinea infections.
    Ely JW; Rosenfeld S; Seabury Stone M
    Am Fam Physician; 2014 Nov; 90(10):702-10. PubMed ID: 25403034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Majocchi granuloma on a child's face.
    André NF; Canato M; Zanatta DA; Gomes IF; Abage KT; Carvalho VO
    Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Widespread tinea corporis in an immunocompetent patient resistant to all conventional forms of treatment.
    Vittorio CC
    Cutis; 1997 Dec; 60(6):283-5. PubMed ID: 9426967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.